Mass spectrometry for comparative proteomics of degenerative and regenerative processes in the brain by Sihlbom, Carina
Mass spectrometry for comparative proteomics of  
degenerative and regenerative processes in the brain 
 
Carina Sihlbom 
Institute of Biomedicine, Sahlgrenska Academy, Göteborg University 
 
 Biological processes involve changes at the protein level. Proteomics aims to 
determine protein changes from a normal state, to measure for instance recovery or 
disease progression. Mass spectrometry is the most important tool for  identification of 
proteins and determination of post-translational modifications such as glycosylation. 
Glycoproteins are found to be altered in patients with Alzheimer's disease (AD). Changes 
in glycosylation levels were quantified after gel separation and glycan structures were 
determined with mass spectrometry. Protein quantification with mass spectrometric 
methods is based on stable isotope labeling of proteins. Quantitative proteomics was 
applied to assess protein expression levels with mass spectrometry in the murine brain 
after specific neurosurgery to study regenerative processes. 
 In order to compare glycosylated proteins in cerebrospinal fluid (CSF) from 
AD patients with control individuals, albumin depleted CSF proteins were separated with 
narrow pH-range two-dimensional gel electrophoresis followed by multiple staining for 
quantification of glycoprotein isoforms. Structural site-specific analysis of glycopeptides 
was performed with Fourier transform ion cyclotron resonance mass spectrometry (FT-
ICR MS). A decreased glycosylation level for α1-antitrypsin was found in AD patients. No 
specific glycoform of the studied proteins could be assigned to AD, emphasizing that 
further studies should include a larger subject group and cover proteins in various pH 
intervals. Knowledge of glycoprotein structures may assist in elucidation of the 
pathogenic process. 
 In order to study proteins involved in the response of astrocytes and 
regenerative processes after neurotrauma, a quantitative mass spectrometric method was 
developed. Astrocytes react to neurotrauma by becoming reactive (reactive gliosis). Mice 
lacking the intermediate filament proteins GFAP and vimentin (GFAP–/–Vim–/–) show 
attenuated reactive gliosis and enhanced regeneration after neurotrauma. Culture-derived 
isotope tags (CDIT) and nano-liquid chromatography FT-ICR MS showed that the 14-3-3 
epsilon isoform was upregulated in denervated hippocampus in wildtype mice, while this 
response was attenuated in GFAP–/–Vim–/– mice. Thus, the increase in 14-3-3 epsilon 
expression in neurotrauma appears to be linked to astrocyte activation. We demonstrated 
that the CDIT-based quantitative proteomic method is a highly useful approach to assess 
isoform-specific protein expression levels in defined parts of the brain after neurosurgical 
interventions.  
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